Cargando…

Methylprednisolone: Disseminated infection due to Sarocladium kiliense following off-label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602492/ http://dx.doi.org/10.1007/s40278-021-05761-0

Ejemplares similares

Fatal disseminated infection due to Sarocladium kiliense in a diabetic patient with COVID‐19
por: Ranjbar‐Mobarake, Maryam, et al.
Publicado: (2021)

Non-valvular Infective Endocarditis Caused by Sarocladium kiliense in an Immunocompromised Patient with Aplastic Anemia
por: Kitamura, Hiroaki, et al.
Publicado: (2021)

Whole-Genome Sequencing to Determine Origin of Multinational Outbreak of Sarocladium kiliense Bloodstream Infections
por: Etienne, Kizee A., et al.
Publicado: (2016)

P269 Managing prosthetic valve endocarditis due to Sarocladium kiliense: Finding a way through uncertainties
por: Rege, Sujata, et al.
Publicado: (2022)

Dexamethasone/hydrocortisone/methylprednisolone: Disseminated cryptococcosis following off label use of dexamethasone, hydrocortisone and methylprednisolone: case report
Publicado: (2022)

Methylprednisolone/tocilizumab: Fatal disseminated mucormycosis following off-label use: case report
Publicado: (2022)

Methylprednisolone/tocilizumab: Disseminated strongyloidiasis and off-label use: case report
Publicado: (2020)

Dexamethasone/methylprednisolone/tocilizumab: Fatal disseminated mucormycosis following off-label use: case report
Publicado: (2022)

Methylprednisolone: Bacteraemia following off label use: case report
Publicado: (2021)

Methylprednisolone: Fungaemia following an off-label use: case report
Publicado: (2022)

Methylprednisolone: Strongyloidiasis following off-label treatment: case report
Publicado: (2022)

Azithromycin/methylprednisolone: Hyperglycaemia following off label use: case report
Publicado: (2020)

Methylprednisolone: Lack of efficacy following off-label use: case report
Publicado: (2022)

Methylprednisolone: Opportunistic infections and off-label-use: 5 case reports
Publicado: (2021)

Methylprednisolone: Decrease in T cell count following off label use: case report
Publicado: (2020)

Methylprednisolone/tocilizumab: Intestinal perforation following off-label use: case report
Publicado: (2020)

Methylprednisolone/tocilizumab: Intestinal perforation following off-label use: case report
Publicado: (2021)

Methylprednisolone/tocilizumab: Gastrointestinal perforation following off label use: case report
Publicado: (2021)

Methylprednisolone/tocilizumab: Cytomegalovirus gastritis following off label use: case report
Publicado: (2022)

Methylprednisolone: Rhino-facial mucormycosis following off label use: case report
Publicado: (2022)

Dexamethasone/methylprednisolone: Sino-orbital mucormycosis infection following off label use: case report
Publicado: (2021)

Corticosteroids/methylprednisolone: Development of ocular-infections following off-label use: 2 case reports
Publicado: (2021)

Methylprednisolone: Worsening hyperglycaemia and off-label use: case report
Publicado: (2021)

Favipiravir/hydroxychloroquine/methylprednisolone: Nephrotoxicity following an off-label use: 2 case reports
Publicado: (2021)

Dexamethasone/methylprednisolone: Various toxicities following off label use: 21 case reports
Publicado: (2022)

Dexamethasone/methylprednisolone: Osteonecrosis of the knee following off-label use: 2 case reports
Publicado: (2022)

Hydroxyzine/methylprednisolone/pheniramine: Lack of efficacy following off label use : case report
Publicado: (2022)

Methylprednisolone/prednisone: Accelerated viral replication following an off-label treatment: case report
Publicado: (2020)

Hydrocortisone/methylprednisolone/tocilizumab: Various toxicities following off-label treatment: case report
Publicado: (2021)

Methylprednisolone: Spontaneous rupture of papillary muscle following off-label treatment: case report
Publicado: (2021)

Methylprednisolone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Dexamethasone/methylprednisolone: Off label use and lack of efficacy: case report
Publicado: (2022)

Dexamethasone/methylprednisolone: Off-label use and cryptococcal meningoencephalitis: case report
Publicado: (2022)

Favipiravir/methylprednisolone: Off-label use and lack of efficacy: case report
Publicado: (2022)

Dexamethasone/methylprednisolone/prednisolone: Avascular necrosis following off-label use:3 case reports
Publicado: (2021)

Baricitinib/methylprednisolone/prednisolone: Elevated HBV DNA following an off label use: case report
Publicado: (2022)

Azithromycin/dexamethasone/methylprednisolone: Aspergillosis, mucormycosis and off-label use: case report
Publicado: (2022)

Methylprednisolone/umifenovir interaction: Sinus bradycardia and off label use: case report
Publicado: (2022)

Methylprednisolone/tocilizumab: Lack of efficacy in off-label use: 7 case reports
Publicado: (2021)

Dexamethasone/methylprednisolone/remdesivir: Off-label use and lack of efficacy: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1f1l9mguqv7qi04hb13ot74lr7